Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Coevolution and HBV drug resistance.

Khudyakov Y.

Antivir Ther. 2010;15(3 Pt B):505-15. doi: 10.3851/IMP1515. Review.

PMID:
20516572
2.

[HBV mutations during antiviral therapy in patients with chronic hepatitis B].

Hwang SG.

Korean J Hepatol. 2005 Dec;11(4):311-9. Korean. No abstract available.

3.
4.

Management of hepatitis B patients with antiviral resistance.

Fung SK, Lok AS.

Antivir Ther. 2004 Dec;9(6):1013-26. Review.

PMID:
15651760
5.

Mutational patterns of hepatitis B virus genome and clinical outcomes after emergence of drug-resistant variants during lamivudine therapy: analyses of the polymerase gene and full-length sequences.

Enomoto M, Tamori A, Kohmoto MT, Morikawa H, Habu D, Sakaguchi H, Takeda T, Seki S, Kawada N, Shiomi S, Nishiguchi S.

J Med Virol. 2007 Nov;79(11):1664-70.

PMID:
17854034
6.

Potential threat of drug-resistant and vaccine-escape HBV mutants to public health.

Teo CG, Locarnini SA.

Antivir Ther. 2010;15(3 Pt B):445-9. doi: 10.3851/IMP1556.

PMID:
20516564
7.

[Definitions of resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].

Zoulim F.

Gastroenterol Clin Biol. 2006 Oct;30(10 Pt 2):3S9-11. Review. French. No abstract available.

8.

Supportive role played by precore and preS2 genomic changes in the establishment of lamivudine-resistant hepatitis B virus.

Ohkawa K, Takehara T, Kato M, Deguchi M, Kagita M, Hikita H, Sasakawa A, Kohga K, Uemura A, Sakamori R, Yamaguchi S, Miyagi T, Ishida H, Tatsumi T, Hayashi N.

J Infect Dis. 2008 Oct 15;198(8):1150-8. doi: 10.1086/591941.

PMID:
18713056
9.

[Entecavir resistance in entecavir naive lamivudine treated chronic hepatitis B patients].

Sayan M, Hülagü S, Akhan SC, Sentürk O, Meriç M, Cekmen M.

Mikrobiyol Bul. 2009 Jul;43(3):425-32. Turkish.

PMID:
19795617
10.

Hepatitis B virus genetic diversity.

Echevarría JM, Avellón A.

J Med Virol. 2006;78 Suppl 1:S36-42.

PMID:
16622876
11.

Treatment of chronic hepatitis B and the implications of viral resistance to therapy.

Mauss S, Wedemeyer H.

Expert Rev Anti Infect Ther. 2008 Apr;6(2):191-9. doi: 10.1586/14787210.6.2.191. Review.

PMID:
18380601
12.

Management of antiviral resistance in patients with chronic hepatitis B.

Locarnini S, Hatzakis A, Heathcote J, Keeffe EB, Liang TJ, Mutimer D, Pawlotsky JM, Zoulim F.

Antivir Ther. 2004 Oct;9(5):679-93. Review.

PMID:
15535405
13.

Hepatitis B virus genotypes and lamivudine resistance mutations in HIV/hepatitis B virus-coinfected patients.

Ramos B, Núñez M, Martín-Carbonero L, Sheldon J, Rios P, Labarga P, Romero M, Barreiro P, García-Samaniego J, Soriano V.

J Acquir Immune Defic Syndr. 2007 Apr 15;44(5):557-61.

PMID:
17224847
14.

[Clinical study of oligonucleotide microarray on monitoring the lamivudine-resistance mutations in hepatitis B virus].

Song JW, Lin JS, Kong XJ, Liang KH.

Zhonghua Gan Zang Bing Za Zhi. 2003 Jun;11(6):361-3. Chinese.

PMID:
12837218
15.

Application of PCR-LDR-nucleic acid detection strip in detection of YMDD mutation in hepatitis B patients treated with lamivudine.

Xu G, You Q, Pickerill S, Zhong H, Wang H, Shi J, Luo Y, You P, Kong H, Lu F, Hu L.

J Med Virol. 2010 Jul;82(7):1143-9. doi: 10.1002/jmv.21811.

PMID:
20513076
16.

[Analysis and recombinant construction of HBV the reverse transcriptase gene with drug-resistant mutations from 40 patients with chronic hepatitis B].

Su HL, Liu Y, Liu W, Zhong YW, Chen XY, Wang CM, Liu YM, Xu DP.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2009 Oct;23(5):340-2. Chinese.

PMID:
20387480
17.

Molecular genesis of drug-resistant and vaccine-escape HBV mutants.

Locarnini SA, Yuen L.

Antivir Ther. 2010;15(3 Pt B):451-61. doi: 10.3851/IMP1499. Review.

PMID:
20516565
18.

Molecular mechanisms of resistance to antiviral therapy in patients with chronic hepatitis B.

Yuan HJ, Lee WM.

Curr Mol Med. 2007 Mar;7(2):185-97. Review.

PMID:
17346170
19.

How to overcome antiviral-resistant hepatitis B virus?

Song BC.

Intervirology. 2010;53(1):29-38. doi: 10.1159/000252781. Epub 2010 Jan 5. Review.

PMID:
20068338
20.

Antiviral therapy of chronic hepatitis B: prevention of drug resistance.

Fournier C, Zoulim F.

Clin Liver Dis. 2007 Nov;11(4):869-92, ix. Review.

PMID:
17981233

Supplemental Content

Support Center